ALITHYA GROUP INC-CLASS A (ALYA)

CA01643B1067 - Common Stock

1.13  +0.03 (+3.2%)

After market: 1.07 -0.06 (-5.31%)

Fundamental Rating

2

Taking everything into account, ALYA scores 2 out of 10 in our fundamental rating. ALYA was compared to 83 industry peers in the IT Services industry. ALYA may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ALYA is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

ALYA had negative earnings in the past year.
ALYA had a positive operating cash flow in the past year.
ALYA had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALYA reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of ALYA (-9.64%) is worse than 64.71% of its industry peers.
The Return On Equity of ALYA (-23.93%) is worse than 62.35% of its industry peers.
Industry RankSector Rank
ROA -9.64%
ROE -23.93%
ROIC N/A
ROA(3y)-5.69%
ROA(5y)-7.52%
ROE(3y)-13.29%
ROE(5y)-15.82%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ALYA's Gross Margin of 27.81% is on the low side compared to the rest of the industry. ALYA is outperformed by 64.71% of its industry peers.
In the last couple of years the Gross Margin of ALYA has declined.
The Profit Margin and Operating Margin are not available for ALYA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-5.34%

1

2. Health

2.1 Basic Checks

ALYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALYA has more shares outstanding
The number of shares outstanding for ALYA has been increased compared to 5 years ago.
The debt/assets ratio for ALYA is higher compared to a year ago.

2.2 Solvency

ALYA has an Altman-Z score of 0.65. This is a bad value and indicates that ALYA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALYA (0.65) is worse than 67.06% of its industry peers.
ALYA has a debt to FCF ratio of 4.61. This is a neutral value as ALYA would need 4.61 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.61, ALYA is in line with its industry, outperforming 55.29% of the companies in the same industry.
ALYA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALYA (0.25) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.61
Altman-Z 0.65
ROIC/WACCN/A
WACC9.02%

2.3 Liquidity

A Current Ratio of 0.69 indicates that ALYA may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.69, ALYA is doing worse than 87.06% of the companies in the same industry.
ALYA has a Quick Ratio of 0.69. This is a bad value and indicates that ALYA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.69, ALYA is doing worse than 87.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69

4

3. Growth

3.1 Past

ALYA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -181.25%.
Looking at the last year, ALYA shows a small growth in Revenue. The Revenue has grown by 6.53% in the last year.
The Revenue has been growing by 29.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)6.53%
Revenue growth 3Y23.28%
Revenue growth 5Y29.23%
Sales Q2Q%-8.07%

3.2 Future

The Earnings Per Share is expected to grow by 28.70% on average over the next years. This is a very strong growth
ALYA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.09% yearly.
EPS Next Y20.37%
EPS Next 2Y38.78%
EPS Next 3Y28.7%
EPS Next 5YN/A
Revenue Next Year-5.2%
Revenue Next 2Y-1%
Revenue Next 3Y0.09%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALYA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALYA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

ALYA's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ALYA is valued cheaper than 94.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.18
EV/EBITDA 20.98

4.3 Compensation for Growth

ALYA's earnings are expected to grow with 28.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.78%
EPS Next 3Y28.7%

0

5. Dividend

5.1 Amount

No dividends for ALYA!.
Industry RankSector Rank
Dividend Yield N/A

ALITHYA GROUP INC-CLASS A

NASDAQ:ALYA (2/8/2024, 8:00:00 PM)

After market: 1.07 -0.06 (-5.31%)

1.13

+0.03 (+3.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-14 2024-02-14/bmo
Earnings (Next)06-06 2024-06-06/amc
Inst Owners0.24%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap99.85M
Analysts78.33
Price Target2 (76.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-163.96%
Min EPS beat(2)-201.66%
Max EPS beat(2)-126.26%
EPS beat(4)0
Avg EPS beat(4)-281.83%
Min EPS beat(4)-747.6%
Max EPS beat(4)-51.8%
EPS beat(8)2
Avg EPS beat(8)-139.12%
EPS beat(12)5
Avg EPS beat(12)-89.58%
EPS beat(16)5
Avg EPS beat(16)-158.75%
Revenue beat(2)0
Avg Revenue beat(2)-8.77%
Min Revenue beat(2)-10.61%
Max Revenue beat(2)-6.92%
Revenue beat(4)0
Avg Revenue beat(4)-5.62%
Min Revenue beat(4)-10.61%
Max Revenue beat(4)-2%
Revenue beat(8)3
Avg Revenue beat(8)-2.34%
Revenue beat(12)6
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)-0.66%
PT rev (1m)-1.16%
PT rev (3m)-20.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-110%
EPS NY rev (1m)0%
EPS NY rev (3m)-112.28%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-8.94%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-6.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF 4.18
P/OCF 4.06
P/B 0.77
P/tB N/A
EV/EBITDA 20.98
EPS(TTM)-0.33
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.27
FCFY23.9%
OCF(TTM)0.28
OCFY24.64%
SpS4.34
BVpS1.47
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.64%
ROE -23.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.81%
FCFM 6.22%
ROA(3y)-5.69%
ROA(5y)-7.52%
ROE(3y)-13.29%
ROE(5y)-15.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-5.34%
F-Score6
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.61
Debt/EBITDA 3.36
Cap/Depr 2.78%
Cap/Sales 0.19%
Interest Coverage N/A
Cash Conversion 253.01%
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 0.65
F-Score6
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)9.34%
Cap/Depr(5y)13.9%
Cap/Sales(3y)0.5%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y20.37%
EPS Next 2Y38.78%
EPS Next 3Y28.7%
EPS Next 5YN/A
Revenue 1Y (TTM)6.53%
Revenue growth 3Y23.28%
Revenue growth 5Y29.23%
Sales Q2Q%-8.07%
Revenue Next Year-5.2%
Revenue Next 2Y-1%
Revenue Next 3Y0.09%
Revenue Next 5YN/A
EBIT growth 1Y-136.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year369.78%
EBIT Next 3Y77.97%
EBIT Next 5YN/A
FCF growth 1Y414.87%
FCF growth 3Y86.26%
FCF growth 5YN/A
OCF growth 1Y507.49%
OCF growth 3Y49.23%
OCF growth 5YN/A